Willis Investment Counsel’s AbbVie ABBV Stock Holding History

Willis Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Buy	1,024 +60	+6%	+$12.9K	0.01%	115
2026 Q1	$210K	Sell	964 -100	-9%	-$22.2K	0.01%	119
2025 Q4	$243K	Sell	1,064 -125	-11%	-$28.5K	0.01%	121
2025 Q3	$275K	Buy	1,189 +48	+4%	+$9.78K	0.02%	114
2025 Q2	$212K	Hold	1,141	–	–	0.01%	115
2025 Q1	$239K	Sell	1,141 -13	-1%	-$2.53K	0.02%	109
2024 Q4	$205K	Buy	1,154 +13	+1%	+$2.39K	0.01%	113
2024 Q3	$225K	Buy	+1,141	New	+$213K	0.01%	109
2024 Q2	–	Sell	-1,141	Closed	-$208K	–	108
2024 Q1	$208K	Buy	+1,141	New	+$197K	0.01%	104
2023 Q2	–	Sell	-1,294	Closed	-$206K	–	111
2023 Q1	$206K	Buy	+1,294	New	+$198K	0.01%	107

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Willis Investment Counsel's ABBV Position: Q2 2026 in Review

Willis Investment Counsel increased its AbbVie (ABBV) stake by 6.2% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,024 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #115.

Willis Investment Counsel first reported a position in ABBV in Q1 2023 and has held it in 10 quarters since. The position peaked at $275K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Willis Investment Counsel held 1,024 shares of AbbVie worth $258K as of Q2 2026.
Willis Investment Counsel bought 60 AbbVie shares in Q2 2026, an estimated $12.9K.
AbbVie made up 0.01% of Willis Investment Counsel's portfolio in Q2 2026, its #115 holding.
Willis Investment Counsel first reported a position in AbbVie in Q1 2023 and has held it in 10 quarters since.
Willis Investment Counsel's AbbVie position peaked at $275K in Q3 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.